# Nuclide record i-123-ioflupane (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/i-123-ioflupane/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "i-123-ioflupane" ;
  schema:name "Ioflupane I-123"@en ;
  schema:alternateName "DaTscan"@en, "DaTSCAN"@en, "123I-FP-CIT"@en, "DaTscan" ;
  schema:description "A brain scan that shows how many dopamine-releasing nerve endings remain in a part of the brain called the striatum, helping tell shaking from Parkinson's-type disease apart from other kinds of tremor and from Alzheimer's-type memory loss."@en ;
  schema:url <https://nuclide.cc/drugs/i-123-ioflupane/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022454s010lbl.pdf>, <https://www.ema.europa.eu/en/documents/product-information/datscan-epar-product-information_en.pdf>, <https://www.ema.europa.eu/en/medicines/human/EPAR/datscan> ;
  nuclide:status "approved" ;
  nuclide:tag "SPECT", "diagnostic", "neurology", "movement disorder" ;
  nuclide:modality "SPECT tracer" ;
  nuclide:approval "US 2011: Striatal dopamine transporter SPECT imaging as an adjunct in adults with suspected Parkinsonian syndromes, to help differentiate essential tremor from tremor due to Parkinsonian syndromes", "EU 2000: Detecting loss of functional dopaminergic neuron terminals in the striatum in clinically uncertain Parkinsonian syndromes, and to help differentiate probable dementia with Lewy bodies from Alzheimer's disease" ;
  nuclide:related <https://nuclide.cc/indications/parkinsonian-syndromes/>, <https://nuclide.cc/indications/alzheimers-disease/>, <https://nuclide.cc/companies/ge-healthcare/>, <https://nuclide.cc/isotopes/i-123/> .